Income Statement Balance Sheet Cash Flow Statement
Annual Financials for PharmAthene Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 27.55M 20.99M 24.27M 25.18M 17.91M
Cost of Goods Sold (COGS) incl. D&A 872,304 1.06M 21.68M - -
COGS excluding D&A 0 0 21.22M - -
Depreciation & Amortization Expense 872,304 1.06M 461,073 303,916 182,487
Depreciation 772,304 900,000 461,073 303,916 182,487
Amortization of Intangibles 100,000 155,865 0 0 0
Gross Income 26.68M 19.94M 2.59M - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 52.65M 38.89M 14.31M 28.84M 24.77M
Research & Development 30.22M 20.88M - 19.51M 14.79M
Other SG&A 22.43M 18.02M 14.31M 9.33M 9.98M
Other Operating Expense 0 0 0 0 0
Unusual Expense 3.65M 10.06M (7.14M) 1.71M 4.24M
EBIT after Unusual Expense (3.65M) (10.06M) 7.14M (1.71M) (4.24M)
Non Operating Income/Expense (90,655) 91,355 821,088 1.28M (6,071)
Non-Operating Interest Income 269,133 6,955 16,660 17,808 2,575
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 2.84M 5.94M 54,573 342,561 369,281
Gross Interest Expense 2.84M 5.94M 54,573 342,561 369,281
Interest Capitalized 0 0 0 0 0
Pretax Income (32.28M) (34.85M) (3.8M) (4.72M) (11.66M)
Income Tax 0 0 0 195,529 61,746
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (32.28M) (34.85M) (3.8M) (4.92M) (11.72M)
Minority Interest Expense 0 0 0 0 0
Net Income (32.28M) (34.85M) (3.8M) (4.92M) (11.72M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (32.28M) (34.85M) (3.8M) (4.92M) (11.72M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (32.28M) (34.85M) (3.8M) (4.92M) (11.72M)
EPS (Basic) (1.17) (1.08) (0.08) (0.10) (0.23)
Basic Shares Outstanding 27.58M 32.31M 47.33M 48.32M 50.66M
EPS (Diluted) (1.17) (1.08) (0.08) (0.10) (0.23)
Diluted Shares Outstanding 27.58M 32.31M 47.33M 48.32M 50.66M
EBITDA (25.1M) (17.9M) (11.26M) (3.66M) (6.86M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.